Hiroyuki Shimizu

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.

CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.

Journal: Cancer medicine

Published: July 10, 2022

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.

Journal: Scientific reports

Published: April 10, 2022

Direct intracranial invasion of eccrine spiradenocarcinoma of the scalp: a case report and literature review.

Direct intracranial invasion of eccrine spiradenocarcinoma of the scalp: a case report and literature review.

Journal: BMC neurology

Published: March 10, 2022

Newly established patient-derived organoid model of intracranial meningioma.

Newly established patient-derived organoid model of intracranial meningioma.

Journal: Neuro-oncology

Published: July 02, 2021

Survival Benefit of Supratotal Resection in a Long-term Survivor of IDH-wildtype Glioblastoma: A Case Report and Literature Review.

Survival Benefit of Supratotal Resection in a Long-term Survivor of IDH-wildtype Glioblastoma: A Case Report and Literature Review.

Journal: NMC case report journal

Published: May 06, 2021

Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas.

Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas.

Journal: Cancer research

Published: March 29, 2021

Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.

Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.

Journal: Journal of neuro-oncology

Published: March 10, 2021

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review.

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review.

Journal: Neuro-oncology advances

Published: October 02, 2020

Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.

Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.

Journal: Journal of neurosurgery

Published: April 22, 2020

Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study.

Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study.

Journal: Journal of neurosurgery

Published: February 28, 2020

Neurod4 converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injury.

Neurod4 converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injury.

Journal: iScience

Published: January 21, 2020

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant.

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant.

Journal: Acta neuropathologica communications

Published: December 03, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026